Research
Raymond James Initiates SpyGlass Pharma at Outperform, With $39 Price Target
SpyGlass Pharma (SGP) has an average rating of buy and mean price target of $44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$SGP
